An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c99b1b5618214a2193bedd33dab46b7d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c99b1b5618214a2193bedd33dab46b7d |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c99b1b5618214a2193bedd33dab46b7d2021-11-30T07:25:38ZAn activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies2001-132610.1002/ctm2.572https://doaj.org/article/c99b1b5618214a2193bedd33dab46b7d2021-11-01T00:00:00Zhttps://doi.org/10.1002/ctm2.572https://doaj.org/toc/2001-1326Alison FindlayCraig TurnerHeidi SchilterMandar DeodharWenbin ZhouLara PerrymanJonathan FootAmna ZahoorYimin YaoRoss HamiltonMary BrockChristina RasoJessica StolpMarie GalatiDieter HamprechtBrett CharltonWolfgang JarolimekWileyarticleMedicine (General)R5-920ENClinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Alison Findlay Craig Turner Heidi Schilter Mandar Deodhar Wenbin Zhou Lara Perryman Jonathan Foot Amna Zahoor Yimin Yao Ross Hamilton Mary Brock Christina Raso Jessica Stolp Marie Galati Dieter Hamprecht Brett Charlton Wolfgang Jarolimek An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| format |
article |
| author |
Alison Findlay Craig Turner Heidi Schilter Mandar Deodhar Wenbin Zhou Lara Perryman Jonathan Foot Amna Zahoor Yimin Yao Ross Hamilton Mary Brock Christina Raso Jessica Stolp Marie Galati Dieter Hamprecht Brett Charlton Wolfgang Jarolimek |
| author_facet |
Alison Findlay Craig Turner Heidi Schilter Mandar Deodhar Wenbin Zhou Lara Perryman Jonathan Foot Amna Zahoor Yimin Yao Ross Hamilton Mary Brock Christina Raso Jessica Stolp Marie Galati Dieter Hamprecht Brett Charlton Wolfgang Jarolimek |
| author_sort |
Alison Findlay |
| title |
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| title_short |
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| title_full |
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| title_fullStr |
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| title_full_unstemmed |
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| title_sort |
activity‐based bioprobe differentiates a novel small molecule inhibitor from a loxl2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/c99b1b5618214a2193bedd33dab46b7d |
| work_keys_str_mv |
AT alisonfindlay anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT craigturner anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT heidischilter anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT mandardeodhar anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT wenbinzhou anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT laraperryman anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT jonathanfoot anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT amnazahoor anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT yiminyao anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT rosshamilton anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT marybrock anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT christinaraso anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT jessicastolp anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT mariegalati anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT dieterhamprecht anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT brettcharlton anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT wolfgangjarolimek anactivitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT alisonfindlay activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT craigturner activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT heidischilter activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT mandardeodhar activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT wenbinzhou activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT laraperryman activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT jonathanfoot activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT amnazahoor activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT yiminyao activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT rosshamilton activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT marybrock activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT christinaraso activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT jessicastolp activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT mariegalati activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT dieterhamprecht activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT brettcharlton activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies AT wolfgangjarolimek activitybasedbioprobedifferentiatesanovelsmallmoleculeinhibitorfromaloxl2antibodyandprovidesrenewedpromiseforantifibrotictherapeuticstrategies |
| _version_ |
1718406773006663680 |